论著

mNGS拟诊重症Ⅰ型单纯疱疹病毒肺炎4例诊治并文献复习

展开
  • 1.上海交通大学医学院附属瑞金医院呼吸与危重症医学科 上海交通大学医学院呼吸疾病研究所上海市呼吸传染病应急防控与诊治重点实验室,上海 200025
    2.太原市太航医院北院内科,山西 太原 030009
第一联系人:*张莉莉和谢思敏为共同第一作者
$\boxed{\hbox{陈虹}}$ E-mail:chenjiangjenny@sina.com

收稿日期: 2023-09-20

  网络出版日期: 2024-04-28

基金资助

上海市临床重点专科(shslczdzk02202);上海市重中之重临床重点学科建设项目(2017ZZ02014);上海市呼吸传染病应急防控与诊治重点实验室(20dz2261100);科委上海市重大传染病科研基地培育项目(20dz2210500)

Severe type Ⅰ herpes virus pneumonia diagnosed by mNGS: 4 cases reports and literature review

Expand
  • 1. Department of Pulmonary and Critical Care Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China;Institute of Respiratory Diseases, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China;Shanghai Key Laboratory of Emergency Prevention, Diagnosis and Treatment of Respiratory Infectious Diseases, Shanghai 200025, China
    2. Department of Internal Medicine, North Taihang Hospital, Taiyuan City, Taiyuan 030009, China

Received date: 2023-09-20

  Online published: 2024-04-28

摘要

目的: 探讨免疫功能正常的重症Ⅰ型单纯疱疹病毒(type Ⅰ herpes simplex virus,HSV-1)肺炎的诊治思路。 方法: 收集和回顾4例2021年4月至12月入住上海交通大学医学院附属瑞金医院呼吸重症监护室(respiratory intensive care unit,RICU)诊断为重症HSV-1肺炎患者的诊治过程,并复习国内外相关文献。4例患者均为男性,年龄72~89岁。结果: 4例患者以发热、咳嗽、咳痰(部分患者有血性痰)、气喘和呼吸困难为主要症状。患者均出现重度Ⅰ型呼吸衰竭,感染指标均上升,同时淋巴细胞计数相对下降,CD3、CD4、CD8绝对计数在治疗后均出现明显上升。呼吸道标本的宏基因组二代测序(metagenomic next generation sequencing, mNGS)中都检测到HSV-1。所有患者采用早期抗病毒、激素抗炎,呼吸支持治疗后,病情均好转,其中3例治愈出院。文献共检索到免疫力低下的HSV-1肺炎26例,免疫功能正常3例。29例患者的临床症状、体征缺乏特异性,经验性给予抗细菌或真菌治疗无效后,多数进一步完善肺泡灌洗液病原学检查,证实HSV-1感染后,积极给予阿昔洛韦抗病毒治疗,部分患者联合激素治疗,3例免疫功能正常者病情均好转,26例免疫力低下者中22例好转,4例死亡。结论高龄重症HSV-1性肺炎临床表现缺乏特异性,诊断存在一定难度。呼吸道分泌物mNGS检查联合常规实验室检查有助于该病的诊断。早期认识该病,予以抗病毒药物,短程使用糖皮质激素治疗可有效治疗该病。

本文引用格式

张莉莉, 谢思敏, 冯耘, $\boxed{\hbox{陈虹}}$ . mNGS拟诊重症Ⅰ型单纯疱疹病毒肺炎4例诊治并文献复习[J]. 内科理论与实践, 2024 , 19(01) : 43 -50 . DOI: 10.16138/j.1673-6087.2024.01.08

Abstract

Objective To explore the diagnosis and treatment of severe type Ⅰ herpes virus (HSV-1) pneumonia patients with normal immune function. Methods Four patients admitted to Ruijin Hospital of Shanghai Jiao Tong University School of Medicine from April 2021 to December 2021 who were diagnosed as severe HSV-1 pneumonia were enrolled, and their clinical data and the relevant domestic and foreign literatures were reviewed. All 4 patients were male, and their age was between 72 and 89 years. Results The main symptoms were fever, cough, expectoration (some patients had bloody sputum), asthma and dyspnea. All patients developed severe type Ⅰ respiratory failure. The infection indicators of all four patients increased, along with a relative decrease in lymphocyte counts, and a significant increase in CD3, CD4, and CD8 absolute counts after treatment. HSV-1 was detected in respiratory specimen using metagenomic next generation sequencing (mNGS) in them. After receiving early antiviral and hormonal anti-inflammatory therapy and respiratory support, the conditions in all four patient improved, and three of them were cured and discharged from the hospital. A total of 26 cases of HSV-1 pneumonia with low immunity and 3 cases with normal immune function were found in the literature, and most of cases lacked specific clinical symptoms and signs. As anti-bacterial or fungal treatment failed, most of them received the etiological examination of alveolar lavage fluid and was confirmed HSV-1 infection. The patients were given acyclovir antiviral therapy, and some patients also got hormone therapy. Three cases with normal immune function and 22 of 26 cases with low immunity showed improved condition, while 4 cases died. Conclusions The clinical symptoms of severe HSV-1 pneumonia lacked specificity and the diagnosis was difficult in elderly patients. mNGS of respiratory secretions combined with routing laboratory tests is helpful to identify the pathogen and make early diagnosis of the disease. The disease can be effectively treated through early recognition of the disease, administration of antiviral drugs, and a short-term treatment of glucocorticoid.

参考文献

[1] Pata R, Datar P. The diagnosis and management of herpes simplex pneumonia in the critical care setting[J]. Cureus, 2023, 15(8): e43224.
[2] Fatahzadeh M, Schwartz RA. Human herpes simplex virus infections: epidemiology, pathogenesis, symptomatology, diagnosis, and management[J]. J Am Acad Dermatol, 2007, 57(5):737-763.
[3] Baj J, Korona-Glowniak I, Buszewicz G, et al. Viral infections in burn patients[J]. Viruses, 2020, 12(11):1315.
[4] Berardi A, Gallo C, Lugli L, et al. Fatal pneumonia following maternal HSV-1 viraemia in late pregnancy[J]. J Matern Fetal Neonatal Med, 2015, 28(14):1694-1696.
[5] Taplitz RA, Kennedy EB, Bow EJ, et al. Antimicrobial prophylaxis for adult patients with cancer-related immunosuppression[J]. J Clin Oncol, 2018, 36(30):3043-3054.
[6] Stephens ML, Mathew A, Banerjee D, et al. COVID-associated pulmonary aspergillosis and herpes simplex virus pneumonia in a renal transplant recipient[J]. Transpl Infect Dis, 2022, 24(6):e13978.
[7] Cunha BA, Eisenstein LE, Dillard T, et al. Herpes simplex virus (HSV) pneumonia in a heart transplant: diagnosis and therapy[J]. Heart Lung, 2007, 36(1):72-78.
[8] Tsoumakas K, Giamaiou K, Goussetis E, et al. Epidemiology of viral infections among children undergoing hematopoietic stem cell transplant[J]. Transpl Infect Dis, 2019, 21(4):e13095.
[9] Bonizzoli M, Arvia R, di Valvasone S, et al. Human herpesviruses respiratory infections in patients with acute respiratory distress (ARDS)[J]. Med Microbiol Immunol, 2016, 205(4):371-379.
[10] Ishihara T, Yanagi H, Ozawa H, et al. Severe herpes simplex virus pneumonia in an elderly, immunocompetent patient[J]. BMJ Case Rep, 2018, 2018:bcr2017224022.
[11] Reyes CV, Bolden JR. Herpes simplex virus type-1 pneumonitis in immunocompetent young woman[J]. Heart Lung, 2009, 38(6):526-529.
[12] Mills B, Ratra A, El-Bakush A, et al. Herpes simplex pneumonia in an immunocompetent patient with progression to organizing pneumonia[J]. J Investig Med High Impact Case Rep, 2014, 2(2):2324709614530560.
[13] Odani K, Tachibana M, Tamashima R, et al. Herpes simplex virus pneumonia: importance of aspiration etiology[J]. Case Rep Pathol, 2019, 2019:7623576.
[14] Eisenstein LE, Cunha BA. Herpes simplex virus pneumonia presenting as failure to wean from a ventilator[J]. Heart Lung, 2003, 32(1): 65-66.
[15] 林秀慧, 张根生, 崔巍. 病毒性肺炎的诊治进展[J]. 中国现代医生, 2017, 55(5): 163-168.
[16] Jellinge ME, Hansen F, Coia JE, et al. Herpes simplex virus type 1 pneumonia[J]. J Intensive Care Med, 2021, 36(12):1398-1402.
[17] 孙雪峰, 柳涛, 蔡柏蔷. 膈肌麻痹35例临床特点分析及文献复习[J]. 中国实用内科杂志, 2011, 31(11): 844-846.
[18] Thorburn F, Bennett S, Modha S, et al. The use of next generation sequencing in the diagnosis and typing of respiratory infections[J]. J Clin Virol, 2015, 69:96-100.
[19] Jeon YJ, Zhou Y, Li Y, et al. The feasibility study of non-invasive fetal trisomy 18 and 21 detection with semiconductor sequencing platform[J]. PLoS One, 2014, 9(10): e110240.
[20] Li H, Durbin R. Fast and accurate short read alignment with Burrows-Wheeler transform[J]. Bioinformatics, 2009, 25(14):1754-1760.
[21] 侯平, 王国涛, 代立娟. 糖皮质激素在病毒性肺炎早期治疗中的作用[J]. 黑龙江医药科学, 2019, 42(5): 72-73.
[22] 杨加伟, 徐金富. 糖皮质激素治疗病毒性肺炎利与弊[J]. 中国实用内科杂志, 2016, 36(2): 133-136.
[23] Iwasaku M, Shinzawa M, Tanaka S, et al. Clinical characteristics of adrenal crisis in adult population with and without predisposing chronic adrenal insufficiency[J]. BMC Endocr Disord, 2017, 17(1):58.
[24] 李彦红. 大剂量丙种球蛋白冲击疗法在成人急性重症病毒性肺炎治疗中的应用效果观察[J]. 国际病毒学杂志, 2015, 22(z1): 75-77.
[25] 刘巍巍. 大剂量丙种球蛋白冲击疗法对成人急性重症病毒性肺炎患者治疗效果的影响[J]. 中国药物经济学, 2017, 12(1): 38-40.
[26] 霍记平, 高婉丽, 赵志刚. 孕产妇高传染性病毒性肺炎的药物治疗方案选择[J]. 临床药物治疗杂志, 2020, 18(4): 66-71.
文章导航

/